About
Bioporto A/s — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 14 2026
Grant of Warrants
Apr 13 2026
Major Shareholder Announcement
Apr 8 2026
BioPorto Successfully Completes Divestment of its Antibody Business to Janel Life Sciences, LLC
Mar 31 2026
BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis
Mar 26 2026
Notice convening the Annual General Meeting in BioPorto A/S
Google Übersetzer